ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 70 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $790,000 | +24.4% | 200,000 | 0.0% | 0.02% | -5.9% |
| Q3 2019 | $635,000 | -75.9% | 200,000 | -23.5% | 0.02% | -66.0% |
| Q3 2017 | $2,640,000 | -74.0% | 261,400 | +161.4% | 0.05% | -90.2% |
| Q2 2017 | $10,164,000 | +101.2% | 100,000 | -60.2% | 0.51% | +77.4% |
| Q1 2017 | $5,051,000 | -61.5% | 251,328 | -70.2% | 0.29% | -69.2% |
| Q4 2016 | $13,128,000 | +15.8% | 842,128 | -3.1% | 0.93% | +27.6% |
| Q3 2016 | $11,339,000 | +94.9% | 868,897 | +2.3% | 0.73% | +81.6% |
| Q2 2016 | $5,818,000 | -27.5% | 849,350 | 0.0% | 0.40% | -42.8% |
| Q1 2016 | $8,026,000 | +42.7% | 849,350 | +52.1% | 0.70% | +69.2% |
| Q4 2015 | $5,623,000 | -66.1% | 558,446 | -51.8% | 0.42% | -37.2% |
| Q3 2015 | $16,580,000 | – | 1,158,700 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |